Description
SMALL PURCHASE DATA
First action · last action
2008-10-22 · 2008-10-22
Transactions
1
First transaction's obligation
$11,740
Base + all options value (sum of deltas)
$11,740
Extent competed
—
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5879X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2008-10-22+$11,740= $11,740
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2008-10-22 | +$11,740 | $11,740 | SMALL PURCHASE DATA |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NG61ZA8TADW3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0394 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $891,651 | FY2026 |
| 36C26226F0314 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $823,062 | FY2026 |
| 36C24526N0724 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $34,874 | FY2026 |
| 36C24526N0622 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $34,874 | FY2026 |
| 36C25026N0416 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $617,297 | FY2026 |
| 36C24526N0566 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $34,874 | FY2026 |
Other recipients under 6505 from 541S-BRECKSVILLE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| V541U10147 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 541S-BRECKSVILLE | $9,285 | FY2011 |
| V541U10155 | PROCARE PHARMACY DIRECT, L.L.C. | 541S-BRECKSVILLE | $3,194 | FY2011 |
| V541Q18369 | PROCARE PHARMACY DIRECT, L.L.C. | 541S-BRECKSVILLE | $3,194 | FY2011 |
| V541P01096 | CAMBER PHARMACEUTICALS INC | 541S-BRECKSVILLE | $10,900 | FY2010 |
| V541A90359 | GENOMIC HEALTH, INC. | 541S-BRECKSVILLE | $3,820 | FY2009 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_V541A90026_3600_V797P5879X_3600 · retrieved 2026-09-27.